Commonwealth Numbered Regulations

NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) AMENDMENT REGULATIONS 2010 (NO.5) (SLI NO 296 OF 2010) - REG 10

         (1)   This regulation applies if:

                 (a)     regulation 6 applies to a listed brand of a pharmaceutical item; and

                (b)     the brand is in the third transitional disclosure cycle.

         (2)   The brand moves to a main disclosure cycle on 1 February 2012.

         (3)   The data collection period for the brand in the main disclosure cycle:

                 (a)     begins on 1 February 2012; and

                (b)     ends at the end of 30 September 2013.

         (4)   The first reporting period in the data collection period for the brand in the main disclosure cycle:

                 (a)     begins on 1 February 2012; and

                (b)     ends at the end of 31 March 2012.